| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038782887 |
| P356 | DOI | 10.1186/S12944-015-0139-6 |
| P932 | PMC publication ID | 4619480 |
| P698 | PubMed publication ID | 26498332 |
| P5875 | ResearchGate publication ID | 283261095 |
| P2093 | author name string | Xin Li | |
| Yuqi Wang | |||
| Zhuoqin Jiang | |||
| Guiyuan Ji | |||
| Yingxun Deng | |||
| P2860 | cites work | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 |
| Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data | Q30622511 | ||
| Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Q34036872 | ||
| Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice | Q34062752 | ||
| Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance | Q34200821 | ||
| LC3 and Autophagy | Q34772075 | ||
| Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18 | Q35038576 | ||
| Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet | Q35976627 | ||
| Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation | Q36007128 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Resveratrol as an anticancer nutrient: molecular basis, open questions and promises | Q36206828 | ||
| Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice | Q36226692 | ||
| Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. | Q36227227 | ||
| Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats | Q37496673 | ||
| Selective degradation of p62 by autophagy | Q37785017 | ||
| Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. | Q38119937 | ||
| Dichloroacetate and Trichloroacetate Toxicity in AML12 Cells: Role of Oxidative Stress. | Q38859097 | ||
| Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats | Q40857241 | ||
| Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy | Q41655355 | ||
| Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway | Q42701853 | ||
| Effect of resveratrol on experimental non-alcoholic steatohepatitis. | Q42702171 | ||
| Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. | Q42704969 | ||
| Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats. | Q42713705 | ||
| Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats | Q42714433 | ||
| Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo | Q46834315 | ||
| Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment. | Q48141180 | ||
| Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. | Q51373751 | ||
| Autophagy induced by resveratrol suppresses α-MSH-induced melanogenesis. | Q53296851 | ||
| Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. | Q54286725 | ||
| Nutraceuticals and dyslipidaemia: Beyond the common therapeutics | Q58464285 | ||
| Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease | Q59594519 | ||
| Statins and hepatic steatosis: perspectives from the Dallas Heart Study | Q80002035 | ||
| Natural history of NAFLD: remarkably benign in the absence of cirrhosis | Q80362865 | ||
| Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease | Q85775732 | ||
| P921 | main subject | autophagy | Q288322 |
| steatosis | Q1365091 | ||
| steatohepatitis | Q2335423 | ||
| P304 | page(s) | 134 | |
| P577 | publication date | 2015-10-24 | |
| P1433 | published in | Lipids in Health and Disease | Q15756695 |
| P1476 | title | Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy | |
| P478 | volume | 14 |
| Q39044686 | A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice. |
| Q37037884 | Alcohol modulates autophagy and apoptosis in pig liver tissue |
| Q94453359 | Analysis of piRNA expression spectra in a non-alcoholic fatty liver disease mouse model induced by a methionine- and choline-deficient diet |
| Q94606183 | Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity |
| Q92497947 | Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction |
| Q60960125 | Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy |
| Q93016049 | Herbal drug discovery for the treatment of nonalcoholic fatty liver disease |
| Q32174749 | Lipid Droplets in Health and Disease |
| Q90031078 | Metabolic Targets in Nonalcoholic Fatty Liver Disease |
| Q59138339 | Metformin: An Old Drug with New Applications |
| Q64252541 | Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease |
| Q39108857 | Recent progression in the utilization of autophagy-regulating nature compound as anti-liver fibrosis agents |
| Q40996168 | Recent studies on resveratrol and its biological and pharmacological activity |
| Q38882789 | Regulation and Functions of Autophagic Lipolysis |
| Q99578629 | Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy |
| Q41444930 | Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats |
| Q90231591 | Resveratrol: A miraculous natural compound for diseases treatment |
| Q37089803 | Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? |
| Q33561060 | Sex Differences in the Effect of Resveratrol on DSS-Induced Colitis in Mice |
| Q37714347 | Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease |
Search more.